Tranquility Partners LLC Has $1.92 Million Holdings in UnitedHealth Group Incorporated $UNH

Tranquility Partners LLC reduced its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 35.4% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,562 shares of the healthcare conglomerate’s stock after selling 3,053 shares during the period. Tranquility Partners LLC’s holdings in UnitedHealth Group were worth $1,921,000 at the end of the most recent quarter.

A number of other institutional investors have also made changes to their positions in the stock. LFA Lugano Financial Advisors SA acquired a new position in UnitedHealth Group during the second quarter valued at approximately $25,000. Sagard Holdings Management Inc. bought a new stake in shares of UnitedHealth Group during the 2nd quarter worth $29,000. Grey Fox Wealth Advisors LLC bought a new position in UnitedHealth Group in the 3rd quarter worth $33,000. Islay Capital Management LLC bought a new stake in UnitedHealth Group during the second quarter valued at about $31,000. Finally, Riggs Asset Managment Co. Inc. increased its stake in shares of UnitedHealth Group by 69.4% in the second quarter. Riggs Asset Managment Co. Inc. now owns 105 shares of the healthcare conglomerate’s stock worth $33,000 after purchasing an additional 43 shares during the period. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Stock Up 2.3%

Shares of UNH opened at $338.47 on Wednesday. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $606.36. The stock has a market cap of $306.60 billion, a price-to-earnings ratio of 17.67, a P/E/G ratio of 2.00 and a beta of 0.42. The company has a 50-day moving average price of $330.76 and a two-hundred day moving average price of $322.56. The company has a quick ratio of 0.82, a current ratio of 0.82 and a debt-to-equity ratio of 0.71.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.87 by $0.05. UnitedHealth Group had a return on equity of 19.23% and a net margin of 4.04%.The business had revenue of $113.16 billion during the quarter, compared to analysts’ expectations of $113.19 billion. During the same period in the prior year, the firm posted $7.15 EPS. UnitedHealth Group’s quarterly revenue was up 12.2% compared to the same quarter last year. Equities analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, December 16th. Stockholders of record on Monday, December 8th were issued a $2.21 dividend. The ex-dividend date of this dividend was Monday, December 8th. This represents a $8.84 annualized dividend and a dividend yield of 2.6%. UnitedHealth Group’s dividend payout ratio is presently 46.14%.

Wall Street Analyst Weigh In

A number of analysts have issued reports on UNH shares. Mizuho raised their target price on UnitedHealth Group from $300.00 to $430.00 and gave the company an “outperform” rating in a report on Thursday, October 9th. Royal Bank Of Canada boosted their target price on shares of UnitedHealth Group from $286.00 to $408.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 29th. TD Cowen raised their price target on shares of UnitedHealth Group from $335.00 to $338.00 and gave the stock a “hold” rating in a research report on Thursday, October 30th. Wells Fargo & Company upped their price objective on shares of UnitedHealth Group from $267.00 to $400.00 and gave the company an “overweight” rating in a research report on Tuesday, October 7th. Finally, Zacks Research upgraded UnitedHealth Group from a “strong sell” rating to a “hold” rating in a research note on Monday, October 6th. One equities research analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating, nine have issued a Hold rating and three have given a Sell rating to the company’s stock. Based on data from MarketBeat.com, UnitedHealth Group has a consensus rating of “Moderate Buy” and an average target price of $385.75.

About UnitedHealth Group

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.